Back to search

National and Kapodistrian University of Athens

Συσχέτιση αδενοκαρκινώματος οισοφάγου με την Β-κατενίνη

Abstract

dc:description

Introduction: Esophageal cancer is considered the ninth most common type of cancer and the sixth leading cause of cancer-related death worldwide. Esophageal adenocarcinoma is associated with aberrant expression of β-Catenin and the transmembrane protein E-Cadherin. The role of β-Catenin is important in intracellular signal transduction through the Wnt pathway, which plays a critical role in the development of esophageal cancer. β-Catenin plays a central role as an adaptor protein, linking E-Cadherin to the actin cytoskeleton, which is essential for maintaining cell adhesion. Aim: To clarify the role of β-Catenin, E-Cadherin and the Wnt pathway, as well as the expression levels of β-Catenin and E-Cadherin as potential biomarkers. Material and method: This study used a pooled sample of eligible anonymized esophagectomy specimens from 71 patients (n=71) with esophageal adenocarcinoma, with or without prior treatments, during the study period (2023-2025), in order to investigate the association between esophageal adenocarcinoma and β-Catenin. The specimens used for this study are archival material from the 1st Laboratory of Pathological Anatomy, Athens Medical School, National and Kapodistrian University of Athens. Results: A total of 71 histopathologically confirmed cases of esophageal adenocarcinoma were examined. After immunohistochemical investigation of the expression of E-Cadherin and B-Catenin, a moderate positive correlation was found between cytoplasmic B-Catenin and TRG (Tumor Regression Grade). A strong positive correlation was also found between cytoplasmic and nuclear B-Catenin expression. Increased cytoplasmic expression was associated with increased nuclear B-Catenin expression, indicating activation of the Wnt pathway. In addition, a positive correlation was found between E-Cadherin and TRG expression. The higher the expression of E-Cadherin, the better the response to treatment.Conclusions: Simultaneous targeting of B-Catenin and E-Cadherin could provide therapeutic benefits in esophageal adenocarcinoma and could potentially be used as prognostic biomarkers.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntourakis, Alexandros
  • Ντουράκης, Αλέξανδρος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60746

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntourakis, Alexandros; Ντουράκης, Αλέξανδρος. Συσχέτιση αδενοκαρκινώματος οισοφάγου με την Β-κατενίνη. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/60746